Breathomics to monitor interstitial lung disease associated with systemic sclerosis.

Exhaled breath analysis, utilising VOCs, offers promise in identifying SSc-ILD patients, aiding targeted treatment. Further multicentric studies are crucial for validation and exploring longitudinal VOC changes for comprehensive disease management. https://bit.ly/4aKMYif.
Competing Interests: Conflict of interest: Outside of this submitted work, B. André reports travel support from Abbvie. Conflict of interest: Outside of this submitted work, R. Louis received unrestricted research grants from GSK, AstraZeneca and Chiesi, and lecture or advisory board fees from GSK and AstraZeneca. Conflict of interest: Outside of this submitted work, J. Guiot received consulting and lectures fees and support for attending meetings from AstraZeneca, Janssens, Chiesi, Roche, GSK and Boehringer Ingelheim, and advisory board fees from GSK, Chiesi, Janssens, AstraZeneca and MSD; and has patents from Radiomics (Oncoradiomics SA). Conflict of interest: The rest of the authors declare that they have no relevant conflicts of interest.
(Copyright ©The authors 2024.)